Início › Câncer de Próstata › Ohio › Columbus
Ensaios clínicos de Câncer de Próstata em Columbus, OH
24 estudos para Câncer de Próstata estão buscando participantes em locais em Columbus e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
RecrutandoFase 3
- Ohio State University Comprehensive Cancer Center, Columbus
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- The Mark H Zangmeister Center, Columbus
- e mais 8
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
RecrutandoFase 2
- Ohio State University Comprehensive Cancer Center, Columbus
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecrutandoFase 2
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- e mais 11
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
RecrutandoFase 2/3
- Central Ohio Urology Group, Gahanna · a 7 mi de distância
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
RecrutandoFase 3
- The Ohio State University, Columbus
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
RecrutandoFase 3
- Central Ohio Urology Group, Gahanna · a 7 mi de distância
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
RecrutandoFase 3
- Research Site, Columbus
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
RecrutandoFase 3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0061), Columbus
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RecrutandoFase 3
- Ohio State University Comprehensive Cancer Center, Columbus
- Riverside Methodist Hospital, Columbus
- Grant Medical Center, Columbus
- e mais 4
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
RecrutandoFase 1/2
- The Ohio State University, Columbus
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
RecrutandoFase 3
- Ohio State University Comprehensive Cancer Center, Columbus
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
RecrutandoFase 1
- The Ohio State University, Columbus
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
RecrutandoFase 1
- The Ohio State University, Columbus
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RecrutandoFase 3
- Ohio State University Comprehensive Cancer Center, Columbus
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
RecrutandoFase 2
- Ohio State University Comprehensive Cancer Center, Columbus
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
RecrutandoFase 1
- The Ohio State University Comprehensive Cancer Center, Columbus
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
RecrutandoFase 1
- Ohio State University-James Cancer Hospital and Solove Research Institute, Columbus
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RecrutandoFase 1/2
- Stefanie Spielman Comprehensive Breast Center, Columbus
Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
RecrutandoFase 2
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RecrutandoFase 1/2
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Columbus
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RecrutandoFase 3
- Ohio State University Comprehensive Cancer Center, Columbus
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
RecrutandoFase 2
- Central Ohio Urology Group, Gahanna · a 7 mi de distância
Ensaios de Câncer de Próstata em outras cidades
- New York City, NY103 estudos
- Houston, TX76 estudos
- Los Angeles, CA61 estudos
- Boston, MA59 estudos
- St. Louis, MO46 estudos
- Chicago, IL45 estudos
- San Francisco, CA45 estudos
- Philadelphia, PA44 estudos
- Baltimore, MD43 estudos
- Nashville, TN42 estudos
- Seattle, WA42 estudos
- Washington, DC38 estudos
Outros estudos em Columbus
- Câncer de Pulmão de Não Pequenas Células56 estudos
- Câncer de Mama39 estudos
- Câncer de Ovário39 estudos
- Câncer (todos os tipos)38 estudos
- Câncer de Pulmão37 estudos
- Leucemia Mieloide Aguda35 estudos
- Leucemia Linfocítica Crônica28 estudos
- Câncer Metastático27 estudos
- Câncer Endometrial25 estudos
- Câncer Colorretal24 estudos
- Mieloma Múltiplo24 estudos
- Melanoma21 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.